Case number 1:18-cv-00777
H. Lundbeck A/S et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 29, 2021 | 17 | Final Judgment (9) |
| Oct 29, 2021 | 17 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks. (Attachments: # (1) Final Judgment) (ntl) |
| Oct 29, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 1090 in lead case no. 18-88-LPS) Associated Cases: 1:18-cv-00113-LPS et al. (ntl) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb) |
| Jan 10, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak) |
| Sep 4, 2018 | 16 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.s Supplemental Initial Disclosures pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) |
| Jul 9, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl) |
| Jul 3, 2018 | 15 | Letter to The Honorable Leonard P. Stark (1) |
| Jul 3, 2018 | 14 | Answer to Counterclaim (13) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack) |
| Jul 3, 2018 | 15 | Main Document (22) Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack) |
| Jun 19, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (13 in 1:18-cv-00753-LPS, 13 in 1:18-cv-00777-LPS, 16 in 1:18-cv-00671-LPS, 14 in 1:18-cv-00672-LPS, 11 in 1:18-cv-00853-LPS) MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/19/18. Associated Cases: 1:18-cv-00671-LPS, 1:18-cv-00672-LPS, 1:18-cv-00753-LPS, 1:18-cv-00777-LPS, 1:18-cv-00853-LPS (ntl) |
| Jun 19, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 18, 2018 | 13 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| Jun 12, 2018 | 11 | Answer to Complaint (29) Docket Text: ANSWER to [1] Complaint, by Lupin Limited and Lupin Pharmaceuticals, Inc, COUNTERCLAIM against All Plaintiffs by Lupin Limited.(Lennon, James) |
| Jun 12, 2018 | 10 | Main Document (23) Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 12, 2018 | 10 | Cover Letter (1) |
| Jun 12, 2018 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James) |
| Jun 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 1:18-cv-00177-LPS, 21 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00114-LPS, 17 in 1:18-cv-00147-LPS, 41 in 1:18-cv-00175-LPS, 15 in 1:18-cv-00092-LPS, 12 in 1:18-cv-00672-LPS, 13 in 1:18-cv-00671-LPS, 28 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00113-LPS, 11 in 1:18-cv-00753-LPS, 9 in 1:18-cv-00777-LPS, 23 in 1:18-cv-00148-LPS, 20 in 1:18-cv-00150-LPS, 20 in 1:18-cv-00176-LPS, 19 in 1:18-cv-00091-LPS, 17 in 1:18-cv-00090-LPS, 16 in 1:18-cv-00149-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/7/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 6, 2018 | 9 | Stipulation to EXTEND Time (14) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| May 23, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (nms) |
| May 23, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceutical Company Ltd., H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc.. Lupin Limited served on 5/22/2018, answer due 6/12/2018. (Blumenfeld, Jack) |
| May 23, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceutical Company Ltd., H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc.. Lupin Pharmaceuticals, Inc. served on 5/22/2018, answer due 6/12/2018. (Blumenfeld, Jack) |
| May 22, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 5/22/2018; Lupin Pharmaceuticals, Inc. on 5/22/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
| May 21, 2018 | 1 | Main Document (14) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2386159.) - filed by Takeda Pharmaceutical Company Ltd., H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(sar) |
| May 21, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharma A/S, Corporate Parent Takeda Europe Holdings B.V. for Takeda Pharmaceuticals International AG; Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals America, Inc., Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (sar) |
| May 21, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (sar) |
| May 21, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1. (sar) |
| May 21, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/9/2018. Date of Expiration of Patent: June 15, 2027.Thirty Month Stay Deadline: 3/30/2021. (sar) |
| May 21, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
| May 21, 2018 | 1 | Civil Cover Sheet (2) |
| May 21, 2018 | 1 | Exhibit A (47) |
| May 21, 2018 | 1 | Complaint* (1) |
